|
GB1419788A
(en)
|
1972-08-02 |
1975-12-31 |
Pfizer |
Herbicidal method using 2-trifuluromethyl-4-quinolinols
|
|
WO1992000075A1
(en)
|
1990-06-29 |
1992-01-09 |
Pfizer Inc. |
Pyridopyrazine derivatives for treating substance abuse and addiction
|
|
DE69315920T2
(de)
|
1992-09-04 |
1998-06-10 |
Takeda Chemical Industries Ltd |
Kondensierte heterozyklische Verbindungen, deren Herstellung und Verwendung
|
|
WO1994017197A1
(en)
|
1993-01-25 |
1994-08-04 |
Takeda Chemical Industries, Ltd. |
ANTIBODY AGAINST β-AMYLOID OR DERIVATIVE THEREOF AND USE THEREOF
|
|
NO309272B1
(no)
|
1995-03-24 |
2001-01-08 |
Takeda Chemical Industries Ltd |
Cykliske forbindelser, preparater inneholdende forbindelsene samt mellomprodukter for fremstilling av forbindelsene
|
|
DE19709877A1
(de)
|
1997-03-11 |
1998-09-17 |
Bayer Ag |
1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
|
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
|
EP2305709A1
(en)
|
1997-04-09 |
2011-04-06 |
Intellect Neurosciences, Inc. |
Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods for use thereof
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
|
AU2787299A
(en)
|
1998-03-03 |
1999-09-20 |
Ppg Industries Ohio, Inc. |
Impregnated glass fiber strands and products including the same
|
|
US20020132817A1
(en)
|
1998-03-19 |
2002-09-19 |
Hideaki Natsugari |
Heterocyclic compounds, their production and use
|
|
AU1409100A
(en)
|
1998-11-27 |
2000-06-19 |
Takeda Chemical Industries Ltd. |
Drugs
|
|
UA75881C2
(en)
|
2000-02-24 |
2006-06-15 |
Univ Washington |
A humanized antibody being associated with beta-amyloid peptide ((a?- polynucleic acid coding it, a pharmaceutical composition containing it, and use of said humanized antibody for making medicinal agent for prophylaxis and treatment of states associated with formation of beta-amyloid plaques
|
|
DE10045112A1
(de)
|
2000-09-11 |
2002-03-21 |
Merck Patent Gmbh |
Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
|
|
JP4708675B2
(ja)
|
2000-11-03 |
2011-06-22 |
プロテオテック・インコーポレーテッド |
ウンカリア・トメントーサおよび関連植物からアミロイド阻害化合物を単離する方法ならびに単離した化合物の使用
|
|
JP2005503789A
(ja)
|
2001-08-17 |
2005-02-10 |
イーライ・リリー・アンド・カンパニー |
抗Ａβ抗体
|
|
US20030195205A1
(en)
|
2001-11-02 |
2003-10-16 |
Pfizer Inc. |
PDE9 inhibitors for treating cardiovascular disorders
|
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
DE10238723A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
|
CA2498111A1
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
|
|
JP2006504725A
(ja)
|
2002-10-09 |
2006-02-09 |
ファイザー・プロダクツ・インク |
神経変性障害治療用ピラゾール化合物
|
|
EP1633786A4
(en)
|
2002-10-09 |
2007-07-25 |
Rinat Neuroscience Corp |
METHOD FOR TREATING ALZHEIMER DISEASE WITH ANTIBODIES TO AMYLOID BETA PEPTIDE AND COMPOSITIONS THEREOF
|
|
WO2004035577A2
(en)
|
2002-10-16 |
2004-04-29 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
WO2004110996A1
(en)
|
2003-06-19 |
2004-12-23 |
Pfizer Products Inc. |
Nk1 antagonist
|
|
JP2007502828A
(ja)
|
2003-08-21 |
2007-02-15 |
ファイザー・プロダクツ・インク |
神経変性性疾患の治療のための化合物
|
|
EP1666061A1
(en)
|
2003-09-09 |
2006-06-07 |
Takeda Pharmaceutical Company Limited |
Use of antibody
|
|
GB0327319D0
(en)
|
2003-11-24 |
2003-12-24 |
Pfizer Ltd |
Novel pharmaceuticals
|
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
|
US20070155731A1
(en)
|
2004-01-28 |
2007-07-05 |
Gabor Butora |
Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
|
|
WO2005080361A1
(en)
|
2004-02-02 |
2005-09-01 |
Pfizer Products Inc. |
Histamine-3 receptor modulators
|
|
CA2557785A1
(en)
|
2004-03-09 |
2005-10-06 |
Merck & Co. Inc. |
Hiv integrase inhibitors
|
|
GEP20084420B
(en)
|
2004-03-23 |
2008-07-10 |
Pfizer Prod Inc |
Use of imidazole compounds for the treatment of neurodegenerative disorders
|
|
EP1742642B1
(en)
|
2004-04-14 |
2008-10-15 |
Gilead Sciences, Inc. |
Phosphonate analogs of hiv integrase inhibitor compounds
|
|
US7456164B2
(en)
|
2004-05-07 |
2008-11-25 |
Pfizer, Inc |
3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
|
|
EP1595881A1
(en)
|
2004-05-12 |
2005-11-16 |
Pfizer Limited |
Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
|
|
SG190665A1
(en)
|
2004-07-30 |
2013-06-28 |
Rinat Neuroscience Corp |
Antibodies directed against amyloid-beta peptide and methods using same
|
|
FR2877015B1
(fr)
|
2004-10-21 |
2007-10-26 |
Commissariat Energie Atomique |
Revetement nanostructure et procede de revetement.
|
|
GB0423356D0
(en)
|
2004-10-21 |
2004-11-24 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
EP1827493A4
(en)
|
2004-12-22 |
2009-09-30 |
Univ St Louis |
USE OF ANTI-ABETA ANTIBODIES FOR THE TREATMENT OF BRAIN TRAUMA
|
|
PE20061323A1
(es)
|
2005-04-29 |
2007-02-09 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
|
|
EP1881825B1
(en)
|
2005-05-10 |
2013-07-24 |
Merck Sharp & Dohme Corp. |
Hiv integrase inhibitors
|
|
KR100939890B1
(ko)
|
2005-05-12 |
2010-01-29 |
화이자 인코포레이티드 |
Ｎ-[1-(2-에톡시에틸)-5-(Ｎ-에틸-Ｎ-메틸아미노)-7-(4-메틸피리딘-2-일-아미노)-1Ｈ-피라졸로[4,3-ｄ]피리미딘-3-카르보닐]메탄술폰아미드의 무수 결정 형태
|
|
WO2006126081A2
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors
|
|
WO2006126083A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
|
|
WO2006126082A2
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
|
|
ATE488496T1
(de)
|
2005-06-22 |
2010-12-15 |
Pfizer Prod Inc |
Histamin-3-rezeptorantagonisten
|
|
US20070060534A1
(en)
|
2005-06-30 |
2007-03-15 |
Threshold Pharmaceuticals, Inc. |
Anthracycline analogs
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
CA2624625A1
(en)
|
2005-11-04 |
2007-05-10 |
Pfizer Limited |
Tetrahydronaphthyridine derivative
|
|
WO2007061923A2
(en)
|
2005-11-18 |
2007-05-31 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
EP1957465A4
(en)
|
2005-11-18 |
2009-04-08 |
Glaxo Group Ltd |
NEW INTERMEDIATE PRODUCTS AND THEIR USE
|
|
CA2629745A1
(en)
|
2005-11-24 |
2007-05-31 |
Eisai R & D Management Co., Ltd. |
Morpholine type cinnamide compound
|
|
US20070117839A1
(en)
|
2005-11-24 |
2007-05-24 |
Eisai R&D Management Co., Ltd. |
Two cyclic cinnamide compound
|
|
WO2007063385A2
(en)
|
2005-12-01 |
2007-06-07 |
Pfizer Products Inc. |
Spirocyclic amine histamine-3 receptor antagonists
|
|
WO2007069053A1
(en)
|
2005-12-14 |
2007-06-21 |
Pfizer Products Inc. |
Benzimidazole antagonists of the h-3 receptor
|
|
AR059075A1
(es)
*
|
2006-01-20 |
2008-03-12 |
Schering Corp |
Bencesulfonil - cromano , tiocromano tetrahidronaftaleno e inhibidores de gamma secretasa relacionados
|
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
|
TWI378091B
(en)
|
2006-03-09 |
2012-12-01 |
Eisai R&D Man Co Ltd |
Multi-cyclic cinnamide derivatives
|
|
US20090163482A1
(en)
|
2006-03-13 |
2009-06-25 |
Mchardy Stanton Furst |
Tetralines antagonists of the h-3 receptor
|
|
EA014919B1
(ru)
|
2006-04-21 |
2011-04-29 |
Пфайзер Продактс Инк. |
ПИРИДИН[3,4-b]ПИРАЗИНОНЫ
|
|
ATE552245T1
(de)
|
2006-05-15 |
2012-04-15 |
Merck Sharp & Dohme |
Antidiabetische bicyclische verbindungen
|
|
EP2066670A2
(en)
|
2006-05-16 |
2009-06-10 |
Gilead Sciences, Inc. |
Integrase inhibitors
|
|
WO2007135969A1
(ja)
|
2006-05-19 |
2007-11-29 |
Eisai R & D Management Co., Ltd. |
ウレア系－シンナミド誘導体
|
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
|
KR101108109B1
(ko)
|
2007-01-22 |
2012-02-06 |
화이자 프로덕츠 인코포레이티드 |
치료 화합물의 토실레이트 염 및 이의 약학 조성물
|
|
AU2008215948A1
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of AD and related conditions
|
|
US8252803B2
(en)
|
2007-02-12 |
2012-08-28 |
Merck Sharp & Dohme Corp. |
Piperidine derivatives
|
|
TW200848054A
(en)
|
2007-02-28 |
2008-12-16 |
Eisai R&D Man Co Ltd |
Two cyclic oxomorpholine derivatives
|
|
WO2008137102A2
(en)
|
2007-05-04 |
2008-11-13 |
Torreypines Therapeutics, Inc. |
Methods of modulating amyloid beta and compounds useful therefor
|
|
US8357682B2
(en)
|
2007-05-07 |
2013-01-22 |
Zhaoning Zhu |
Gamma secretase modulators
|
|
RU2009140182A
(ru)
|
2007-05-11 |
2011-06-20 |
Ф. Хоффманн-Ля Рош Аг (Ch) |
Гетариланилины в качестве модуляторов для бета-амилоида
|
|
TW200908968A
(en)
|
2007-05-29 |
2009-03-01 |
Sgx Pharmaceuticals Inc |
Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
|
|
WO2008153792A2
(en)
|
2007-06-01 |
2008-12-18 |
Schering Corporation |
Gamma secretase modulators
|
|
EP2152695A2
(en)
|
2007-06-01 |
2010-02-17 |
Schering Corporation |
Gamma secretase modulators
|
|
US8242150B2
(en)
|
2007-06-13 |
2012-08-14 |
Merck Sharp & Dohme Corp. |
Triazole derivatives for treating alzheimer'S disease and related conditions
|
|
CA2692253A1
(en)
|
2007-06-29 |
2009-01-08 |
Schering Corporation |
Gamma secretase modulators
|
|
CA2695543A1
(en)
|
2007-08-06 |
2009-02-12 |
Schering Corporation |
Gamma secretase modulators
|
|
JP5433418B2
(ja)
|
2007-08-31 |
2014-03-05 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
多環式化合物
|
|
US7935815B2
(en)
|
2007-08-31 |
2011-05-03 |
Eisai R&D Management Co., Ltd. |
Imidazoyl pyridine compounds and salts thereof
|
|
MX2010002674A
(es)
|
2007-09-06 |
2010-03-25 |
Schering Corp |
Moduladores de gamma secretasa.
|
|
CA2700964A1
(en)
|
2007-09-28 |
2009-04-09 |
Schering Corporation |
Gamma secretase modulators
|
|
GB0720444D0
(en)
|
2007-10-18 |
2007-11-28 |
Glaxo Group Ltd |
Novel compounds
|
|
MX2010005028A
(es)
|
2007-11-05 |
2010-05-27 |
Schering Corp |
Moduladores de gamma secretasa.
|
|
EP2229375A1
(en)
|
2007-12-06 |
2010-09-22 |
Schering Corporation |
Gamma secretase modulators
|
|
JP2011506460A
(ja)
|
2007-12-11 |
2011-03-03 |
シェーリング コーポレイション |
γ−セクレターゼモジュレーター
|
|
US8426595B2
(en)
|
2007-12-11 |
2013-04-23 |
Xianhai Huang |
Gamma secretase modulators
|
|
CN101896461A
(zh)
|
2007-12-13 |
2010-11-24 |
安姆根有限公司 |
γ分泌酶调节剂
|
|
AU2009203773B2
(en)
|
2008-01-11 |
2013-04-18 |
F. Hoffmann-La Roche Ag |
Modulators for amyloid beta
|
|
CN101952275B
(zh)
|
2008-02-22 |
2014-06-18 |
弗·哈夫曼-拉罗切有限公司 |
β-淀粉样蛋白的调节剂
|
|
US20100137320A1
(en)
|
2008-02-29 |
2010-06-03 |
Schering Corporation |
Gamma secretase modulators
|
|
CA2716747A1
(en)
|
2008-02-29 |
2009-09-03 |
Schering Corporation |
Gamma secretase modulators for the treatment of alzheimer's disease
|
|
BRPI0912539A2
(pt)
|
2008-05-05 |
2015-10-13 |
Amgen Inc |
composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
|
|
FR2933700B1
(fr)
*
|
2008-07-08 |
2010-07-30 |
Sanofi Aventis |
Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
|
|
TW201006801A
(en)
|
2008-07-18 |
2010-02-16 |
Lilly Co Eli |
Imidazole carboxamides
|
|
EP2312946A4
(en)
|
2008-08-13 |
2012-10-24 |
Merck Sharp & Dohme |
PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
|
|
US20110251172A1
(en)
|
2008-08-13 |
2011-10-13 |
Rivkin Alexey A |
Purine derivatives for treatment of alzheimer's disease
|
|
EP2324009A1
(en)
|
2008-08-27 |
2011-05-25 |
Eisai R&D Management Co., Ltd. |
Process for preparing certain cinnamide compounds
|
|
MX2011003246A
(es)
|
2008-10-09 |
2011-04-21 |
Hoffmann La Roche |
Moduladores de beta amiloide.
|
|
CA2742317A1
(en)
|
2008-11-06 |
2010-05-14 |
Schering Corporation |
Gamma secretase modulators
|
|
JP2012508180A
(ja)
|
2008-11-06 |
2012-04-05 |
シェーリング コーポレイション |
γ−セクレターゼ調節剤
|
|
JP2012507512A
(ja)
|
2008-11-06 |
2012-03-29 |
アストラゼネカ・アクチエボラーグ |
アミロイドβのモジュレーター
|
|
CN102209537A
(zh)
|
2008-11-10 |
2011-10-05 |
弗·哈夫曼-拉罗切有限公司 |
杂环γ分泌酶调节剂
|
|
US20110313001A1
(en)
|
2008-12-16 |
2011-12-22 |
Christian Fischer |
Triazole derivatives for treatment of alzheimer's disease
|
|
WO2010071741A1
(en)
|
2008-12-16 |
2010-06-24 |
Merck Sharp & Dohme Corp. |
Triazole derivatives for treatment of alzheimer's disease
|
|
PA8854101A1
(es)
|
2008-12-18 |
2010-07-27 |
Ortho Mcneil Janssen Pharm |
Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
|
|
DK2379525T3
(en)
|
2008-12-19 |
2015-10-19 |
Boehringer Ingelheim Int |
Cyclic pyrimidin-4-carboxamides, as CCR2 receptor antagonists for the treatment of inflammation, asthma and COPD
|
|
US8759337B2
(en)
|
2008-12-22 |
2014-06-24 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
TW201035103A
(en)
|
2008-12-22 |
2010-10-01 |
Schering Corp |
Gamma secretase modulators
|
|
TW201030002A
(en)
|
2009-01-16 |
2010-08-16 |
Bristol Myers Squibb Co |
Bicyclic compounds for the reduction of beta-amyloid production
|
|
BRPI1008473A2
(pt)
|
2009-02-06 |
2019-04-02 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
compostos heterocíclicos bicíclicos substituídos como moduladores de gama secretase
|
|
TWI461425B
(zh)
|
2009-02-19 |
2014-11-21 |
Janssen Pharmaceuticals Inc |
作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類
|
|
CN102333778B
(zh)
|
2009-02-26 |
2015-05-13 |
卫材R&D管理有限公司 |
四氢三唑并吡啶衍生物的盐及其晶体
|
|
JP2012121809A
(ja)
|
2009-02-26 |
2012-06-28 |
Eisai R & D Management Co Ltd |
多環式化合物の製造法およびその中間体
|
|
JP2012051805A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
テトラヒドロトリアゾロピリジン誘導体の製造方法
|
|
JP2012051807A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
アリールイミダゾール化合物
|
|
JP2012051806A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
イミダゾリルピラジン誘導体
|
|
CA2751534A1
(en)
|
2009-03-03 |
2010-09-10 |
Pfizer Inc. |
Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
|
|
RU2532470C2
(ru)
|
2009-08-07 |
2014-11-10 |
ДАУ АГРОСАЙЕНСИС ЭлЭлСи |
Пестицидные композиции
|
|
JP2013508350A
(ja)
*
|
2009-10-20 |
2013-03-07 |
ファイザー・インク |
ガンマ−セクレターゼモジュレーターとしての新規なヘテロアリールイミダゾールおよびヘテロアリールトリアゾール
|
|
ES2655391T3
(es)
*
|
2009-12-22 |
2018-02-19 |
Vertex Pharmaceuticals Incorporated |
Inhibidores isoindolinona de fosfatidilinositol 3-quinasa
|
|
EP2691393B1
(en)
|
2011-03-31 |
2016-09-14 |
Pfizer Inc |
Novel bicyclic pyridinones
|
|
CA2870347C
(en)
*
|
2012-05-16 |
2020-08-04 |
Janssen Pharmaceuticals, Inc. |
Substituted 3, 4 - dihydro - 2h - pyrido [1, 2 -a] pyrazine - 1, 6 - dione derivatives useful for the treatment of (inter alia) alzheimer's disease
|
|
TWI614238B
(zh)
|
2012-09-21 |
2018-02-11 |
必治妥美雅史谷比公司 |
雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥
|
|
UA110688C2
(uk)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Біциклічні піридинони
|
|
CN104918938B
(zh)
|
2012-12-20 |
2017-08-15 |
詹森药业有限公司 |
新颖的作为γ分泌酶调节剂的三环3，4‑二氢‑2H‑吡啶并[1，2‑a]吡嗪‑1，6‑二酮衍生物
|
|
KR102171710B1
(ko)
|
2013-01-17 |
2020-10-30 |
얀센 파마슈티카 엔.브이. |
감마 세크레타제 조절 인자로서의 신규 치환 피리도-피페라지논 유도체
|
|
WO2015049616A1
(en)
|
2013-10-04 |
2015-04-09 |
Pfizer Inc. |
Novel bicyclic pyridinones as gamma-secretase modulators
|
|
CN115068134B
(zh)
|
2014-03-21 |
2024-11-19 |
阿莱恩技术有限公司 |
具有弹性体的分段的正畸矫正器
|
|
AU2015242330B2
(en)
|
2014-04-01 |
2017-08-17 |
Pfizer Inc. |
Chromene and 1,1 a,2,7b-tetrahydrocyclopropa[c]chromene pyridopyrazinediones as gamma-secretase modulators
|